: The company and its subsidiaries have completed the signing of the project entry contract with an investment of 450 million yuan.

Lianhuan Pharmaceutical announced that on April 27, 2026, the company approved relevant proposals to invest in the "Science and Technology Innovation Center Project" and the "Pharmaceutical Precision Cold Chain Manufacturing Center Project" in Yangzhou High-tech Zone, with planned total investments of 150 million yuan and 300 million yuan respectively. Recently, the company and its holding subsidiary, Lianhuan Marketing, have signed the "Project Entry Contract" with the Yangzhou High-tech Zone Management Committee. If there are significant changes or progress in the future, the company will disclose them in a timely manner.